Die Westpfalz-Klinikum GmbH ist eine Trägergesellschaft für die Kliniken in Kaiserslautern, Kirchheimbolanden, Kusel, Rockenhausen und weitere Tochterfirmen mit Sitz in Kaiserslautern.

During the past decade, Westpfalz-Klinikum GmbH conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Westpfalz-Klinikum GmbH" #1 sponsor was "German CLL Study Group" with 9 trials, followed by "Biotronik SE & Co. KG" with 3 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "GWT-TUD GmbH" with 2 trials sponsored and "Technische Universität Dresden" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Westpfalz-Klinikum GmbH" #1 collaborator was "Bayer" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Nordic CLL Study Group (NCLLSG)" with 2 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Westpfalz-Klinikum GmbH" are "Chronic Lymphocytic Leukemia" (8 trials), "Heart Failure" (4 trials), "Acute Myeloid Leukemia (AML)" (2 trials), "Leukemia" (2 trials) and "Acute Ischemic Stroke" (1 trials). Many other conditions were trialed in "Westpfalz-Klinikum GmbH" in a lesser frequency.

Most popular intervention types in "Westpfalz-Klinikum GmbH" are "Drug" (20 trials), "Biological" (11 trials), "Procedure" (6 trials), "Device" (5 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Fludarabine" (5 trials), "Rituximab" (4 trials), "cyclophosphamide" (3 trials), "peripheral blood stem cell transplantation" (3 trials) and "radiation therapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "Westpfalz-Klinikum GmbH" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Westpfalz-Klinikum GmbH". 1 are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Westpfalz-Klinikum GmbH, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Westpfalz-Klinikum GmbH, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".

Westpfalz-Klinikum GmbH has several departments that took part in Clinical trials: "Westpfalz-Klinikum, Klinik für Innere Medizin I" - 2 trials